Felbamate Suspension
Product Images NDC 51672-4172

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Felbamate (NDC 51672-4172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Taro Pharmaceuticals U.s.a., Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Felbamate 01)

FDA Label Image

Principal Display Panel (237 mL Bottle Label)

Principal Display Panel (237 mL Bottle Label)
NDC 51672-4172-1 is a prescription drug, Felbamate, available in the form of 81 oz (237 mL) Oral Suspension USP with a strength of 600 mg/5 mL. Each five milliliter contains Felbamate. It is recommended to dispense the medication guide to each patient. The standard dosage should be consulted while prescribing. The suspension should be stored in a container and under controlled conditions of 20 - 25°C (68 - 77°F) room temperature. The drug is manufactured and supplied by Taro Pharmaceuticals USA Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.